# REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction

> **NCT00378352** · PHASE2 · COMPLETED · sponsor: **National Institute on Aging (NIA)** · enrollment: 223 (actual)

## Conditions studied

- Acute ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Epoetin alfa

## Key facts

- **NCT ID:** NCT00378352
- **Lead sponsor:** National Institute on Aging (NIA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-07
- **Final completion:** 2011-01
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00378352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00378352, "REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00378352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*